United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News ServiceTitan stock jumps 13.6% as Q2 results top estimates, non-GAAP income more than doubles ServiceTitan shares surged 13.6% after Q2 earnings showed strong SaaS growth and non-GAAP profitability. Find out what’s driving investor optimism. byPallavi MadhirajuSeptember 6, 2025